Literature DB >> 29406280

Absence of protection from West Nile virus disease and adverse effects in red legged partridges after non-structural NS1 protein administration.

Belén Rebollo1, Francisco Llorente2, Elisa Pérez-Ramírez3, Javier Sarraseca4, Carmina Gallardo5, María Ángeles Risalde6, Ursula Höfle7, Jordi Figuerola8, Ramón C Soriguer9, Ángel Venteo10, Miguel Ángel Jiménez-Clavero11.   

Abstract

The red-legged partridge (Alectoris rufa) is a competent host for West Nile virus (WNV) replication and highly susceptible to WNV disease. With the aim to assess in this species whether the inoculation of non-structural protein NS1 from WNV elicits a protective immune response against WNV infection, groups of partridges were inoculated with recombinant NS1 (NS1 group) or an unrelated recombinant protein (mock group), and challenged with infectious WNV. A third group received no inoculation prior to challenge (challenge group). The NS1 group failed to elicit detectable antibodies to NS1 while in the mock group a specific antibody response was observed. Moreover, no protection against WNV disease was observed in the NS1 group, but rather, it showed significantly higher viral RNA load and delayed neutralizing antibody response, and suffered a more severe clinical disease, which resulted in higher mortality. This adverse effect has not been observed before and warrants further investigations.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adverse effects; Avian; Flavivirus; Immunization; In-vivo; NS1; Red-legged partridge; West Nile virus

Mesh:

Substances:

Year:  2018        PMID: 29406280     DOI: 10.1016/j.cimid.2017.12.006

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  2 in total

1.  Role of NS1 and TLR3 in Pathogenesis and Immunity of WNV.

Authors:  Sameera Patel; Alessandro Sinigaglia; Luisa Barzon; Matteo Fassan; Florian Sparber; Salome LeibundGut-Landmann; Mathias Ackermann
Journal:  Viruses       Date:  2019-07-03       Impact factor: 5.048

2.  Monitoring Anti-NS1 Antibodies in West Nile Virus-Infected and Vaccinated Horses.

Authors:  Belén Rebollo; Javier Sarraseca; Sylvie Lecollinet; Nabil Abouchoaib; Javier Alonso; Ignacio García-Bocanegra; Antonio J Sanz; Ángel Venteo; Miguel A Jiménez-Clavero
Journal:  Biomed Res Int       Date:  2018-09-25       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.